Christopher Paul German - 14 Feb 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Corporate Controller & CAO
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Christopher Paul German
Issuer symbol
RYTM
Transactions as of
14 Feb 2025
Net transactions value
-$36,335
Form type
4
Filing time
19 Feb 2025, 21:45:16 UTC
Previous filing
03 Apr 2024
Next filing
24 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +1,807 +201% 2,705 16 Feb 2025 Direct F1, F2
transaction RYTM Common Stock Sale $36,335 -635 -23% $57.22 2,070 19 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Award $0 +7,225 $0.000000 7,225 14 Feb 2025 Common Stock 7,225 Direct F1, F4
transaction RYTM Stock Options (Right to Buy) Award $0 +5,400 $0.000000 5,400 14 Feb 2025 Common Stock 5,400 $56.69 Direct F5
transaction RYTM Restricted Stock Units Options Exercise $0 -1,807 -25% $0.000000 5,418 16 Feb 2025 Common Stock 1,807 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
F3 The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
F4 The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
F5 The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F6 The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney